Lung Cancer
From the Journals
SBRT vs Surgery in CRC Lung Metastases: Which Is Better?
Researchers compared outcomes among 335 patients with lung metastases from CRC who underwent surgery or SBRT.
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
News from the FDA/CDC
FDA OKs First-Line Lazertinib With Amivantamab for NSCLC
The approval was based on results from the phase 3 MARIPOSA trial.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
From the Journals
Few Severe Toxicities After SBRT in Oligometastatic Cancer
SBRT, an alternative to chemotherapy and immunotherapy, offers treatment with a low rate (0.5%) of severe acute toxicities.
Commentary
It’s Never Too Late to Convince Patients to Quit Smoking
Quitting before age 50 nearly eliminated the excess mortality associated with smoking, and in the 50- to 59-year-old age group, cessation...
News from the FDA/CDC
FDA Approves Neoadjuvant/Adjuvant Durvalumab for NSCLC
The drug was approved alongside platinum-containing chemotherapy in the neoadjuvant setting and as monotherapy in the adjuvant setting.
From the Journals
Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?
Researchers evaluated 31,257 patients with advanced NSCLC from Japan who received immune checkpoint inhibitors or conventional chemotherapy.
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...